Diprifusor (Target-controlled infusion)
DeviceTwo TCI devices with different Teo and same Marsh PK model
Other names: Diprifusor(Grasby Medical Limited, United Kingdom)
NCT Number: NCT01091350
The aim of this study is to validate that an effect compartment concentration for loss of consciousness (LOC) was varied according to different Keo value.
Looking for future studies?
Notify Me20 year–60 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two TCI devices with different Teo and same Marsh PK model
Other names: Diprifusor(Grasby Medical Limited, United Kingdom)
Two TCI devices with different Teo and same Marsh PK model
Other names: OrchestraTM (Fresenius Vial, Brezins, France)
Time frame: after propofol infusion
Time frame: after propofol infusion
Seoul National University Hospital
Other
Influence of Equilibration Rate Constant (ke0) of Propofol on the Effect-site Concentration for Loss of Consciousness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07040631
Breast Cancer, Breast Diseases
Yangsan, Gyeongsangnam-do, South Korea
View Trial DetailsNCT07199049
Eye Movements, General Anesthesia
Başakşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06787196
Bone Cysts, Cysts
Selçuklu, Konya, Turkey (Türkiye)
View Trial DetailsNCT00775879
General Anesthesia
Bordeaux, France
View Trial Details